(주)유유제약 · KOSPI: 000220 · Pharmaceuticals and medicinal chemicals
| KRW | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | ₩137.2B | ₩133.1B | ₩140.9B |
| Operating income | ₩365M | ₩11.7B | ₩11.0B |
| Net income | −₩5.5B | ₩10.3B | ₩9.1B |
| Total assets | ₩198.2B | ₩207.7B | ₩207.2B |
| Total liabilities | ₩77.9B | ₩72.6B | ₩66.7B |
| Total equity | ₩120.4B | ₩135.1B | ₩140.5B |
| Share capital | ₩20.2B | ₩20.2B | ₩20.2B |
Consolidated statements · FY2025 operating margin 7.8% · liabilities to equity 47% · Annual report FY2025 (Korean original)
| Period | Auditor | Opinion |
|---|---|---|
| Term 86 (current) | 삼일회계법인 | Unqualified |
| Term 85 (prior) | 신우회계법인 | Unqualified |
| Term 84 (two years prior) | 신우회계법인 | Unqualified |
| Date | Largest shareholder (Korean) | Stake | Cause (Korean) |
|---|---|---|---|
| 2020년 04월 28일 | 유원상 외 11인 | — | 주1) |
| Date | Filing | Original |
|---|---|---|
| 2026-08-13 | Half-year report (2026.06) | DART |
| 2026-07-31 | Amended: Decision to acquire tangible assets | DART |
| 2026-07-21 | Large shareholding (5%+) report | DART |
| 2026-07-01 | Large shareholding (5%+) report | DART |
| 2026-06-16 | Officer / major shareholder ownership report | DART |
| 2026-06-08 | Share cancellation decision | DART |
| 2026-05-29 | Corporate governance report | DART |
| 2026-05-15 | Quarterly report (2026.03) | DART |
| 2026-04-21 | Change in shareholdings of largest shareholder | DART |
| 2026-04-21 | Large shareholding (5%+) report | DART |
| 2026-03-26 | Independent director appointment / dismissal / resignation | DART |
| 2026-03-26 | Annual general meeting results | DART |
| 2026-03-24 | Corporate value-up plan (voluntary) | DART |
| 2026-03-18 | Annual report (2025.12) | DART |
| 2026-03-18 | Audit report submitted | DART |
| 2026-03-10 | Notice of shareholders meeting | DART |
| 2026-02-26 | Resolution to convene shareholders meeting | DART |
| 2026-02-26 | Cash / in-kind dividend decision | DART |
| 2026-02-03 | Change in shareholdings of largest shareholder | DART |
| 2026-02-03 | Large shareholding (5%+) report | DART |
Showing the 20 most recent of 26 filings. The full brief lists all of them.
For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).
Data generated 2026-09-16 from OpenDART.
This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.